← Back to patent-cliff list
伊格列净L-脯氨酸盐
Tier C — Watch / tradeIpragliflozin L-Proline
安斯泰来制药集团
Originator
2014
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SGLT2
Brand：Suglat
Indications (approved)：二型糖尿病、一型糖尿病
Regional status
US
无进展
2008-10-23
EU
无进展
2010-04-06
China
临床一期
2013-01-25
Japan
批准上市
2014-01-17
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ipragliflozin L-Proline?
Approved indications include: 二型糖尿病, 一型糖尿病.
When does the Ipragliflozin L-Proline patent expire?
No public expiry year is available for Ipragliflozin L-Proline yet; this page updates once verified.
How do I get a quote for Ipragliflozin L-Proline intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25